Furthermore, we also found three relevant studies (Kim et al., 2013b; Park et al., 2015; Siddiqi et al., 2014) that evaluated the effects of G-Rg5/G-Rk1 co-treatment on cell viability of gastric cancer cells, mice, and MC3T3-E1 cells. This evidence concerns the gene GRK1 and gastric cancer.